Africa Unveils Lenacapavir HIV-Prevention Injection, Studies Reveal 99.9% Risk Reduction
World
F
Firstpost•01/12/2025
Africa Unveils Lenacapavir HIV-Prevention Injection, Studies Reveal 99.9% Risk Reduction
- •New HIV-prevention injection rolled out in Africa.
- •Lenacapavir reduces HIV transmission risk by 99.9%.
- •South Africa, Eswatini, and Zambia begin administering lenacapavir.
- •Lenacapavir costs $28,000 per person annually in the US.
- •Generic versions expected by 2027 at around $40 per year.
Why it matters: This could greatly reduce HIV transmission rates in regions with the highest global burden.
✦
Related Articles
Loading more articles...
